Which hedge funds own XRAY? DENTSPLY SIRONA INC, Q2 2026 13F holders
42 tracked hedge funds disclosed a position in XRAY (DENTSPLY SIRONA INC) in their Q2 2026 13F filings, worth $427.2m in total. The largest holder by portfolio weight is Atlantic Investment Management, Inc. at 12.2% of its book. 9 opened a new position this quarter: Bayforest Capital Ltd, Capricorn Fund Managers Ltd, EntryPoint Capital, LLC, 111 Capital. 13 exited: Tejara Capital Ltd, Freestone Grove Partners LP, Lecap Asset Management Ltd.
- 42
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $8.1m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $43.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $427m
- Combined value Sum of the holders' reported positions in the security.
- 3.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Tejara Capital Ltd | 0.3% | $800k |
| Freestone Grove Partners LP | 0.2% | $26.6m |
| Lecap Asset Management Ltd | 0.2% | $419k |
| Scientech Research LLC | 0.1% | $168k |
| iSAM Funds (UK) Ltd | 0.1% | $250k |
| Catalyst Funds Management Pty Ltd | 0.06% | $339k |
| Fox Run Management, L.L.C. | 0.05% | $297k |
| Woodline Partners LP | 0.03% | $8.1m |
| Caption Management, LLC | 0.03% | $580k |
| Jain Global LLC | 0.01% | $780k |
| Schonfeld Strategic Advisors LLC | 0.01% | $627k |
| Magnetar Financial LLC | 0.0% | $467k |
| Arrowstreet Capital, Limited Partnership | 0.0% | $3.9m |
Ownership over time
Who discovered XRAY first? Beta
| Pura Vida Investments, LLC | Q3 2017 | +0.5 pts |
| Orbimed Advisors LLC | Q2 2018 | −0.2 pts |
| Alyeska Investment Group, L.P. | Q1 2016 | −0.2 pts |
| Select Equity Group, L.P. high conviction | Q1 2016 | −0.4 pts |
| Arrow Capital Management, LLC high conviction | Q2 2016 | −0.4 pts |
| Ruane, Cunniff & Goldfarb (Sequoia Fund) high conviction | Q2 2016 | −0.7 pts |
| Viking Global Investors LP | Q4 2017 | −0.7 pts |
| Continental Advisors LLC | Q4 2018 | −1.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.